Berkshire medtech firm Occuity has announced two major patent milestones as the firm continues to bolster its leading position in Oculomics – the study of the eye as a barometer of overall human health.
The company revealed it had been granted a patent covering its high-speed scanning approach used across all its products. This patent encompasses a design, which allows precise scanning over a long range at over 200 scans per second.
READ MORE: Berkshire-based Occuity seals £2.85M investment to develop revolutionary medical technology with multiple uses
Secondly, Occuity is also developing a non-invasive screening tool on the eye to detect diabetes, predicted to affect 1.3 billion people by 2050, and revealed it had recently filed a patent as part of this Innovate UK-supported SD1 project.
The technology builds on the company’s existing PM1 and AX1 optical platforms and is a critical enabler in the development of compact, handheld devices that will be both accessible and cost-effective.
Related: Azalea Vision Announces First On-Eye test of ALMA, its Revolutionary Smart Contact Lens
Dr Robin Taylor, the chief technology officer (CTO) and co-founder of Occuity said: “Screening for chronic diseases is something that I and the Occuity team are deeply passionate about; we hope to fundamentally change the approach to healthcare with a move toward preventative medicine.
“This patent application is a huge step toward our long-term goal of achieving an easy-to-develop, cost-effective, screening tool for chronic diseases such as Diabetes and Alzheimer’s Disease,” he added.
On the company’s scanning patent win, he said this was “crucial” in protecting a key enabling technology fundamental to achieving the firm’s mission of “assessing someone’s health by simply performing a quick scan of their eye”.
Occuity CEO and co-founder Dr Dan Daly summed up: “The patent grant and this new patent application not only secures our unique technology but also enhances our position as a leader in the growing field of Oculomics.
“They are vital components in our mission to use the eye as a window into the overall health of the body.
It’s a testament to our potential in the field of optical scanning and eye health and advances our mission to transform disease detection, diagnosis, and management through non-invasive techniques.”
Occuity is focused on the eye and specialises in developing non-invasive optical devices for disease screening and monitoring.
